Oxford Nanopore, the company delivering a new generation of nanopore-based molecular sensing technology, and Day Zero Diagnostics (DZD)
Wakefield, Mass., November 7, 2023 – Myrtelle Inc. (“Myrtelle” or the “Company”), a clinical-stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases…
Wakefield, Mass., November 7, 2023 – Myrtelle Inc. (“Myrtelle” or the “Company”), a clinical-stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases…
Day Zero Diagnostics selected to deliver two presentations at the 2023 ID Week conference and present AI-based antimicrobial susceptibility
Day Zero Diagnostics selected to deliver two presentations at the 2023 ID Week conference and present AI-based antimicrobial susceptibility